1. Home
  2. ICUI vs RNW Comparison

ICUI vs RNW Comparison

Compare ICUI & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • RNW
  • Stock Information
  • Founded
  • ICUI 1984
  • RNW 2011
  • Country
  • ICUI United States
  • RNW United Kingdom
  • Employees
  • ICUI N/A
  • RNW N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • RNW Electric Utilities: Central
  • Sector
  • ICUI Health Care
  • RNW Utilities
  • Exchange
  • ICUI Nasdaq
  • RNW Nasdaq
  • Market Cap
  • ICUI 3.4B
  • RNW 2.7B
  • IPO Year
  • ICUI 1992
  • RNW N/A
  • Fundamental
  • Price
  • ICUI $127.40
  • RNW $7.60
  • Analyst Decision
  • ICUI Strong Buy
  • RNW Strong Buy
  • Analyst Count
  • ICUI 5
  • RNW 1
  • Target Price
  • ICUI $196.75
  • RNW $7.50
  • AVG Volume (30 Days)
  • ICUI 186.2K
  • RNW 996.5K
  • Earning Date
  • ICUI 08-07-2025
  • RNW 08-14-2025
  • Dividend Yield
  • ICUI N/A
  • RNW N/A
  • EPS Growth
  • ICUI N/A
  • RNW 16.07
  • EPS
  • ICUI N/A
  • RNW 0.13
  • Revenue
  • ICUI $2,420,093,000.00
  • RNW $1,135,947,896.00
  • Revenue This Year
  • ICUI N/A
  • RNW N/A
  • Revenue Next Year
  • ICUI N/A
  • RNW $17.90
  • P/E Ratio
  • ICUI N/A
  • RNW $60.07
  • Revenue Growth
  • ICUI 7.22
  • RNW 19.36
  • 52 Week Low
  • ICUI $117.92
  • RNW $5.15
  • 52 Week High
  • ICUI $196.26
  • RNW $7.77
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 46.81
  • RNW 58.47
  • Support Level
  • ICUI $124.39
  • RNW $7.46
  • Resistance Level
  • ICUI $134.04
  • RNW $7.64
  • Average True Range (ATR)
  • ICUI 3.75
  • RNW 0.14
  • MACD
  • ICUI 0.18
  • RNW -0.03
  • Stochastic Oscillator
  • ICUI 47.55
  • RNW 49.23

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks: